Institution: | Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacology and Toxicology, University Hospital Basel, 4031 Basel, Switzerland; Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, MA, U.S.A.; MerckSerono SA, Geneva, Switzerland |